Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1290000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of stock acquisition rights with exercise price adjustment clauses
発行・処分する株式数1,290,000Shares
1,290,000 new shares
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
¥168, ¥158 and ¥156. Details of the adjustment clauses and the floor price are not disclosed in this document.
Number of Stock Acquisition Rights
Total issued: 100,000 rights; unexercised at the end of the previous month: 72,800 rights; currently unexercised: 59,900 rights
Most recent equity financing
Issued on 10 November 2025: issuance by way of a third-party allotment of new shares, the 2025 First Series of Stock Acquisition Rights (with a fixed exercise price) and the 2025 Second Series of Stock Acquisition Rights (with exercise price adjustment clauses). The amount is not disclosed in this document.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of stock acquisition rights with exercise price adjustment clauses |
| Number of shares to be issued or disposed of | 1,290,000 new shares |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Total number of issued shares | 26,004,392 shares (including 78,009 treasury shares) → Not disclosed |
| Exercise price | ¥168, ¥158 and ¥156. Details of the adjustment clauses and the floor price are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; unexercised at the end of the previous month: 72,800 rights; currently unexercised: 59,900 rights |
| Most recent equity financing | Issued on 10 November 2025: issuance by way of a third-party allotment of new shares, the 2025 First Series of Stock Acquisition Rights (with a fixed exercise price) and the 2025 Second Series of Stock Acquisition Rights (with exercise price adjustment clauses). The amount is not disclosed in this document. |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This notice reports the status of the large-scale exercise. No specific reason for the large-scale exercise is disclosed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.